Tetrahedracanabinol, commonly referred to as THC, is the main psychoactive chemical compound found in cannabis.  Now how would you go about labeling this type of drug? Since the Controlled Substances Act came into legislation in 1970 the government has had their own labeling process in effect.  This legislation created five “schedules”, with each category possessing varying qualifications for a substance to be placed into.

A substance that is labeled as a “schedule 1” drug is determined to have no medicinal legitimacy as well as a high potential for abuse.  Some common drugs in this category are heroin, LSD, and EVEN marijuana.  Now who determines which drugs have what label? Well the Drug Enforcement Agency (DEA) shares this power with the Food and Drug Administration (FDA).  Apparently, they are the ones capable of the decision making process that goes into deciding if a substance is medically “legitimate”.

Progressively, there have been more and more medical studies taking place to test the medical implications of marijuana on various symptoms and diseases.  This includes nausea, insomnia, and pain to serious diseases such as AIDS, Alzheimers, cancer, brain tumors, and multiple sclerosis.   However, due to marijuana’s illegality, along with its label as medically insignificant, there has been hardly any funding and research dedicated to the matter.

For summarized medical marijuana studies as well as full articles and research please click here: Marijuana Research


The Weed Street Journal Team